Our mission

First-in-class Targets, Best-in-class Vaccines

iPSC-based vaccination represents a novel approach to cancer treatment

with the ability to engage a multi-faceted anti-tumor response

Board of Directors

Scientific Advisors

View profile

Ian Frazer, MD, PhD

CEO & Director of Research/Professor Translational Research Institute/University of Queensland
View profile

John Zalcberg, MD, PhD

Head of Cancer Research Monash University
View profile

Ronald Levy, MD

Robert K. and Helen K. Summy Professor Stanford School of Medicine

For Investors

Learn more about what we do and how you can get involved.

Working at Khloris Biosciences.